A comparison of the toxicity of two formulations of Corynebacterium parvum in a double-blind crossover trial in patients with bronchogenic carcinoma.
D000368:Aged; D001428:Bacterial Vaccines / Q000627:therapeutic use / Q000633:toxicity*; D002283:Carcinoma, Bronchogenic / Q000628:therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005334:Fever / Q000209:etiology; D005612:Freeze Drying; D006358:Hot Temperature; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011425:Propionibacterium acnes / Q000276:immunology*; D014839:Vomiting / Q000209:etiology
D001428:Bacterial Vaccines